NL6600250A - - Google Patents

Info

Publication number
NL6600250A
NL6600250A NL6600250A NL6600250A NL6600250A NL 6600250 A NL6600250 A NL 6600250A NL 6600250 A NL6600250 A NL 6600250A NL 6600250 A NL6600250 A NL 6600250A NL 6600250 A NL6600250 A NL 6600250A
Authority
NL
Netherlands
Application number
NL6600250A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6600250A publication Critical patent/NL6600250A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL6600250A 1965-01-12 1966-01-10 NL6600250A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Publications (1)

Publication Number Publication Date
NL6600250A true NL6600250A (xx) 1966-07-13

Family

ID=4186481

Family Applications (2)

Application Number Title Priority Date Filing Date
NL128191D NL128191C (xx) 1965-01-12
NL6600250A NL6600250A (xx) 1965-01-12 1966-01-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL128191D NL128191C (xx) 1965-01-12

Country Status (11)

Country Link
US (1) US3350400A (xx)
BE (1) BE674919A (xx)
BR (1) BR6676358D0 (xx)
CH (1) CH458365A (xx)
DE (1) DE1545772B1 (xx)
DK (1) DK114482B (xx)
ES (1) ES321531A1 (xx)
FR (2) FR1463438A (xx)
GB (1) GB1084150A (xx)
IT (1) IT7830644A0 (xx)
NL (2) NL6600250A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032554A (en) * 1962-05-01 Process for the preparation of new
US3029239A (en) * 1954-04-17 1962-04-10 Chemiewerk Homburg Zweignieder Basic substituted 1-and 7-alkylxanthines or salts thereof
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen
DE1018869B (de) * 1954-12-14 1957-11-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Aminoalkylpurinderivaten
DE1112983B (de) * 1958-11-21 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Theophyllin-Derivaten
CH402872A (de) * 1959-12-18 1965-11-30 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten

Also Published As

Publication number Publication date
CH458365A (de) 1968-08-30
FR5128M (xx) 1967-06-05
DK114482B (da) 1969-07-07
BR6676358D0 (pt) 1973-09-06
ES321531A1 (es) 1966-11-01
US3350400A (en) 1967-10-31
GB1084150A (xx)
DE1545772B1 (de) 1969-12-11
BE674919A (xx) 1966-07-11
IT7830644A0 (it) 1978-12-06
FR1463438A (fr) 1966-12-23
NL128191C (xx)

Similar Documents

Publication Publication Date Title
FI45384B (xx)
FR5128M (xx)
FR2053820A5 (xx)
JPS4317689Y1 (xx)
FR4585M (xx)
FR1585861A (xx)
JPS4329396Y1 (xx)
JPS5333521B1 (xx)
JPS4428178Y1 (xx)
BE675221A (xx)
BE674991A (xx)
NL6608294A (xx)
BE659312A (xx)
AU6783465A (xx)
BE681573A (xx)
BE675781A (xx)
BE675779A (xx)
BE675771A (xx)
BE675746A (xx)
BE675734A (xx)
BE659435A (xx)
BE675660A (xx)
BE675596A (xx)
BE675440A (xx)
BE674362A (xx)